Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies

Ann Surg Oncol. 2023 Sep;30(9):5323-5326. doi: 10.1245/s10434-023-13641-x. Epub 2023 May 16.

Authors

Kristen E Rhodin¹, Vignesh Raman², Elishama Kanu², Austin Eckhoff², Daniel P Nussbaum², Michael E Lidsky², Dan G Blazer 3rd²

Affiliations

¹ Department of Surgery, Duke University School of Medicine, Durham, NC, USA. kristen.rhodin@duke.edu.
² Department of Surgery, Duke University School of Medicine, Durham, NC, USA.

PMID: 37191858
PMCID: PMC10526627 (available on 2024-09-01)
DOI: 10.1245/s10434-023-13641-x

No abstract available

Publication types

Letter

MeSH terms

Humans
Neoplasms*
Patient Selection
Upper Gastrointestinal Tract*

Grants and funding